Skip to main content

Table 1 In vitro anti-plasmodial, cytotoxic and haemolytic activity of crude extracts and pure compound (1) obtained from Dicoma tomentosa (n = 3)

From: Anti-plasmodial activity of Dicoma tomentosa (Asteraceae) and identification of urospermal A-15-O-acetate as the main active compound

Pure compound

Yield (in the plant)

IC503D7 μg/ml (μM)

IC50W2 μg/ml (μM)

IC50WI38 μg/ml (μM)

SI 3D7

SI W2

Haemolysis (%)

Compound 1 = urospermal-15-O-acetate (MM = 320.34)

0.64%

0.92 ± 0.05 (= 2.87 ± 0.16)

0.77 ± 0.25 (= 2.41 ± 0.78)

3.03 ± 0.18 ( = 9.47 ± 0.56)

3.3

3.9

< 1%

Extracts

Yield (%)

IC 50 3D7 (μg/ml)

IC 50 W2 (μg/ml)

IC 50 WI38 (μg/ml)

SI 3D7

SI W2

Haemolysis (%)

Petroleum ether

1.8%

23.2 ± 3.1

21.2 ± 2.2

22.0 ± 0.6

0.9

1.0

< 1%

Hexane

1.7%

18.7 ± 2.9

17.7 ± 1.2

32.9 ± 4.0

1.8

1.9

< 1%

Dichloromethane

5.4%

3.4 ± 1.2

1.9 ± 0.2

11.5 ± 0.4

3.3

6.1

< 1%

Diethylether

3.4%

3.9 ± 0.6

4.8 ± 0.7

6.5 ± 1.4

1.6

1.3

< 1%

Ethylacetate

4.1%

4.4 ± 1.1

4.6 ± 0.3

5.9 ± 0.6

1.3

1.3

< 1%

Methanol

11.1%

5.8 ± 2.0

3.0 ± 0.5

19.9 ± 5.4

3.5

6.7

< 1%

Ethanol 50% (v/v)

16.2%

12.9 ± 3.0

9.7 ± 1.1

28.4 ± 2.9

2.2

2.9

< 1%

Hot water

20.3%

12.8 ± 2.4

6.7 ± 1.0

47.2 ± 2.9

3.7

7.0

< 1%

  1. SI = selectivity index = IC50(WI38)/IC50(3D7 or W2, respectively)
  2. Standard drugs: artemisinin (3D7): IC50 = 0.0067 ± 0.0018 μg/ml; artemisinin (W2): IC50 = 0.0034 ± 0.0009 μg/ml; chloroquine (3D7): IC50 = 0.016 ± 0.004 μg/ml; chloroquine (W2): IC50 = 0.35 ± 0.08 μg/ml; camptothecin (WI-38): IC50 = 0.029 ± 0.011 μg/ml.